CIK 0001528115
- Non-accelerated filer
- Smaller reporting company
Annexon, Inc.
Sign in to watch- Ticker
- ANNX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 275414423
- Phone
- +1 650-822-5500
- Business address
- 1400 SIERRA POINT PARKWAY, BLDG C, SUITE 200, BRISBANE, CA, 94005
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale EVP & Chief Financial Officer sold 3,500 shares at $22.24 ($77,835)
- 4 Open-market sale President & CEO sold 7,602 shares at an average $28.11 ($213,662)
- 4 Open-market sale President & CEO sold 7,500 shares at an average $24.97 ($187,300)
- 4 Open-market sale EVP & Chief Scientific Officer sold 16,175 shares at an average $28.80 ($465,770)
- 4 Open-market sale EVP & Chief Medical Officer sold 3,995 shares at $30.17 ($120,512)
- 4 Open-market sale EVP & Chief Financial Officer sold 5,000 shares at an average $28.44 ($142,176)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy 10% owner bought 200,000 shares at $17.00 ($3,400,000)
- 4 Conversion 10% owner acquired 1,596,222 shares (conversion)
- 4 Open-market buy 10% owner bought 400,000 shares at $17.00 ($6,800,000)
- 4 Open-market buy EVP & Chief Financial Officer bought 2,000 shares at $17.00 ($34,000)
Page 9 of 11 · 206 filings